key: cord-1018897-u3mtac3j
authors: Aras, Mohini; Tchang, Beverly G.; Crawford, Andrew; Bledsoe, Melissa; Fujioka, Ken; Aronne, Louis J.
title: Impact of Telemedicine During the COVID‐19 Pandemic on Patient Attendance
date: 2021-05-07
journal: Obesity (Silver Spring)
DOI: 10.1002/oby.23180
sha: 34b3c2ddb0ef3d00dd27d3e6433411038406d53a
doc_id: 1018897
cord_uid: u3mtac3j

nan

We conducted a cohort comparison study of all new and follow-up visits in 2019 and 2020 at two multispecialty, insurance-based, comprehensive weight-management centers. Monthly appointment data for scheduled, completed, and cancelled visits with physicians, nurse practitioners, and/or physician assistants were extracted, and the no-show rate was calculated as the percentage of noncompleted visits in relationship to the total number of scheduled visits over each month and cumulatively over 1 year. No-show rates were compared descriptively between each month of 2019 and 2020 ( Figure 1 ). In 2019, there were 4,673 no-show visits of the 29,629 scheduled visits (15.8% no-show rate), and in 2020, there were 2,824 no-show visits of the 24,633 scheduled visits (11.5% no-show rate), representing a significant 27.2% reduction in the annual no-show rate (χ 2 P < 0.05). With the transition to telemedicine, there has been a rise in completed new and follow-up visits, as well as a reduction in no-show visits.

The cause for improved appointment adherence is likely multifactorial. With the need for obesity treatment far exceeding the number of trained obesity medicine specialists, patients may travel significant distances for appropriate care and often face other common barriers (e.g., taking time off from work, arranging childcare). Telemedicine removes these barriers and saves patients both time and cost (3). Lastly, obesity being a risk factor for increased COVID-19 severity could be incentivizing patients to prioritize obesity treatment (4).

Weight-loss outcomes are improved with better attendance and adherence (5) , which telemedicine has significantly improved during the COVID-19 pandemic. Further studies are necessary to evaluate clinical weight outcomes in the setting of video visits versus in-person visits and the utility of implementing telemedicine into standard clinical practice. Telemedicine is posed to be an instrumental tool for delivering effective obesity management.O Disclosure: LA declared receiving consulting fees from, and serving on, advisory boards for ERX, Jamieson Laboratories, Pfizer, Novo Nordisk, Sanofi, Janssen, UnitedHealth Group Ventures, and Gelesis; receiving research funding from Lilly, Janssen, Allurion, and Novo Nordisk; having an equity interest in Intellihealth, ERX, Zafgen, Gelesis, MYOS, and Jamieson Laboratories; and serving on a board of directors for MYOS, Intellihealth, and Jamieson Laboratories outside the Letter to the Editor 

What COVID-19 is teaching us about counseling for weight management

COVID-19 emergency declaration blanket waivers for health care providers

The impact of telemedicine on patients' cost savings: some preliminary findings

Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships

Predictors of successful weight loss outcomes amongst individuals with obesity undergoing lifestyle interventions: a systematic review

Correspondence: Mohini Aras (moa9031@ med.cornell.edu) 2 Center for Weight Management at Scripps Health